Skip to main content
Premium Trial:

Request an Annual Quote

Affymetrix Plans Notes Offering of $105M to Help Pay for eBioscience Acquisition

NEW YORK (GenomeWeb News) – Affymetrix intends to offer $105 million in convertible senior notes due 2019, it announced after the close of the market on Monday.

The proceeds from the offering, which was made pursuant to a $200 million shelf registration filed by the Santa Clara, Calif.-based microarray firm late last month, will be used to pay for part of its proposed buy of eBioscience for $315 million. Affy has a commitment letter from General Electric Capital and Silicon Valley Bank in the principal amount of $100 million for the acquisition, which is expected to close in the second quarter.

Citigroup and Morgan Stanley are joint book-running managers for the offering. Affy said it anticipates granting the two investment banks the option to purchase up to $10 million aggregate principal amount of additional notes to cover over-allotments, if any.

The eBioscience acquisition had been expected to close by the end of 2011, when it was originally announced in November with a purchase price of $330 million. A lawsuit delayed the deal, though, and Affy had to restructure the purchase.

The Scan

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.

Study Looks at Parent Uncertainties After Children's Severe Combined Immunodeficiency Diagnoses

A qualitative study in EJHG looks at personal, practical, scientific, and existential uncertainties in parents as their children go through SCID diagnoses, treatment, and post-treatment stages.

Antimicrobial Resistance Study Highlights Key Protein Domains

By screening diverse versions of an outer membrane porin protein in Vibrio cholerae, researchers in PLOS Genetics flagged protein domain regions influencing antimicrobial resistance.

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.